Corrigendum to "A novel method to produce synthetic murine CXCL10 for efficient screening of functional variants" [Bioorg. Chem. 116 (2021) 105376]
Bioorg Chem
.
2022 Mar:120:105655.
doi: 10.1016/j.bioorg.2022.105655.
Epub 2022 Feb 5.
Authors
Jérémie Decalf
1
,
Jeffrey Tom
2
,
Elaine Mai
3
,
Hilda Hernandez-Barry
3
,
Cameron L Noland
4
,
Breanna S Vollmar
5
,
Alice Li
5
,
Hong Li
5
,
Daniel Xie
6
,
Lunchao Zhu
6
,
Jian Payandeh
4
,
Kelly M Loyet
3
,
Cong Wu
3
,
Laetitia Comps-Agrar
3
,
Christine Moussion
7
,
Matthew L Albert
7
,
Aimin Song
8
Affiliations
1
Department of Cancer Immunology, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA. Electronic address:
[email protected]
.
2
Department of Early Discovery Biochemistry, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
3
Department of Biochemical and Cellular Pharmacology, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
4
Department of Structural Biology, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
5
Department of Protein Chemistry, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
6
TideMed Pharma, Room 1-1115, No. 291, Fucheng Road, Hangzhou Qiantang New Area, Hangzhou 310018, China.
7
Department of Cancer Immunology, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
8
Department of Early Discovery Biochemistry, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA. Electronic address:
[email protected]
.
PMID:
35134644
DOI:
10.1016/j.bioorg.2022.105655
No abstract available
Publication types
Published Erratum